关于耐卡巴胺肠杆菌的最新情况:来自印度西部的前性研究
1Department of Microbiology, Mahatma Gandhi Medical College, Jaipur, Rajasthan, India.
Journal of postgraduate medicine
|June 9, 2025
概括
耐卡巴胺的肠道细菌 (CRE) 构成重大威胁,其流行率很高,并观察到卡巴胺酶的产生. 单独Ceftazidime-avibactam (CZA) 显示出有限的活性,但与aztreonam具有协同效应,强调需要持续监测.
科学领域:
- 医学微生物学 医学微生物学
- 传染性疾病 传染性疾病
- 抗微生物耐药性 抗微生物耐药性
背景情况:
- 抗微生物药物耐药性,特别是耐卡巴胺肠道细菌 (CRE),是一个日益严重的全球健康问题.
- CRE感染与显著的发病率和死亡率有关.
- 了解CRE的流行病学和耐药性机制对于有效治疗至关重要.
研究的目的:
- 提供关于耐卡巴胺肠道细菌 (CRE) 的全面更新.
- 描述CRE的流行率,抗菌素敏感性和基因型特征.
- 为了评估Ceftazidime-avibactam (CZA) 对CRE分离物的体外活性.
主要方法:
- 印度一家三级医院的前性观察研究.
- 从临床样本中包括连续的非重复的CRE分离物.
- 碳酶生产的表型检测 (mCIM,eCIM) 和基因型分析 (多重PCR).
主要成果:
- CRE的患病率为43%,其中91%为碳烯酶生产者.
- 对常见的抗生素有很高的耐药性;观察到对tigecycline (94%) 和colistin (91%) 的敏感性.
- 单独Ceftazidime-avibactam (CZA) 显示了33%的敏感性,但与aztreonam.com有93%的协同作用. bla OXA-48 是最常见的基因 (61.4%).
结论:
- 这项研究强调了CRE感染的不断升级的威胁.
- 对CRE的持续监测对于指导抗微生物治疗至关重要.
- CZA与阿兹特里奥纳姆的协同活性需要进一步研究临床应用.
更多相关视频
相关概念视频
Antibiotic Selection
Overview
Acute Pyelonephritis II: Diagnostic Studies and Management
Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...
Antimicrobial Effectiveness
The effectiveness of antimicrobial agents depends on various factors influencing their ability to eliminate microbial populations. Larger microbial populations require more time for complete eradication, emphasizing the importance of population size analysis when evaluating antimicrobial efficacy.Microbial resistance to antimicrobial agents varies significantly. Highly resilient microorganisms include endospores, gram-negative bacteria, and non-enveloped viruses, while prions are exceptionally...
Development of Antibiotic Resistance
Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
Mechanism of Antibiotic Resistance in MRSA
Antibiotic resistance in bacteria arises when microorganisms evolve the ability to withstand drugs designed to kill them or inhibit their growth, rendering once-effective treatments useless. This phenomenon, driven by genetic change and selection under antibiotic exposure, poses a profound threat to modern medicine. Mechanisms include drug-inactivating enzymes (e.g., β-lactamases), efflux pumps that eject antibiotics, mutations altering antibiotic targets, decreased drug uptake, and acquisition...
Clinical Significance of Antibiotic Resistance
Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...


